(19)
(11) EP 2 582 791 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.05.2018 Bulletin 2018/21

(45) Mention of the grant of the patent:
28.03.2018 Bulletin 2018/13

(21) Application number: 11796538.4

(22) Date of filing: 17.06.2011
(51) International Patent Classification (IPC): 
A61L 27/24(2006.01)
A61L 27/60(2006.01)
A61F 2/10(2006.01)
 A61L 27/38(2006.01)
C12N 5/071(2010.01)
A61K 35/36(2015.01)
(86) International application number:
PCT/US2011/040937
(87) International publication number:
WO 2011/160055 (22.12.2011 Gazette 2011/51)

(54)

HAIR FOLLICLE NEOGENESIS

NEOGENESE VON HAARFOLLIKELN

NÉOGENÈSE DE FOLLICULES PILEUX

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 18.06.2010 US 344258 P

(43) Date of publication of application:
24.04.2013 Bulletin 2013/17

(73) Proprietor: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Bethesda, MD 20817 (US)

(72) Inventors:
  • THANGAPAZHAM, Rajesh
    Rockville, MD 20851 (US)
  • DARLING, Thomas, N.
    Rockville, MD 20850 (US)
  • LI, Shaowei
    Potomac, MD 20854 (US)

(74) Representative: Dörries, Hans Ulrich 
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16
80333 München
80333 München (DE)


(56) References cited: : 
WO-A1-00/29553
WO-A2-03/055990
US-A1- 2002 120 950
 WO-A1-91/16010
WO-A2-2006/097701
US-A1- 2005 214 344
   
  • CRISTIANE H. SQUARIZE ET AL: "Accelerated Wound Healing by mTOR Activation in Genetically Defined Mouse Models", PLOS ONE, vol. 5, no. 5, 1 May 2010 (2010-05-01), page e10643, XP055088225, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0010643
  • O'CALLAGHAN ET AL: "Tuberous sclerosis complex", 20080111, vol. 18, no. 1, 11 January 2008 (2008-01-11), pages 30-36, XP022412956,
  • ANTHONY D. METCALFE ET AL: "Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration", JOURNAL OF THE ROYAL SOCIETY INTERFACE, vol. 4, no. 14, 5 December 2006 (2006-12-05), pages 413-437, XP055088237, ISSN: 1742-5689, DOI: 10.1098/rsif.2006.0179
  • RITSUKO EHAMA ET AL: "Hair Follicle Regeneration Using Grafted Rodent and Human Cells", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 127, no. 9, 12 April 2007 (2007-04-12), pages 2106-2115, XP055088241, ISSN: 0022-202X, DOI: 10.1038/sj.jid.5700823
  • SHAOWEI LI ET AL: "Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis", NATURE COMMUNICATIONS, vol. 2, 8 March 2011 (2011-03-08), page 235, XP055088144, DOI: 10.1038/ncomms1236
  • LI ET AL.: 'Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis' NATURE COMMUNICATIONS vol. 2, 08 March 2011,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).